Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials show barzolvolimab significantly improves UAS7 and complete response rates in antihistamine-refractory CSU.

Out of all of the hematological parameters examined, only neutrophil-to-monocyte ratio was associated with ocular involvement in rosacea.

The FDA has updated labeling for Kybella (deoxycholic acid) to warn clinicians of persistent nodules, masses, and adverse events linked to off-label use.

Significant imbalances in sex hormones and oxidative stress were seen among women with severe acne vulgaris when compared with healthy controls.

Nearly two-thirds of suspected poisonings in children can be handled by a call to a poison control center and do not require an ED visit.

The FDA has accepted an NDA with Priority Review for oral dersimelagon to treat erythropoietic protoporphyria and X-linked protoporphyria.

All participating US comprehensive cancer centers are experiencing a shortage of at least one anticancer agent.

A dairy-free frozen dessert has been recalled for the second time in 9 months because its cashew pieces may contain small stones.

Research is needed on the real-world performance of clinical AI tools in dermatology, yet many patients use available consumer-facing tools.

A coroner has confirmed that measles killed 1 infant last month, but federal officials still are not counting the death in their tally.

Aminolevulinic acid hydrochloride in combination with photodynamic therapy has been approved for the treatment of BCC.

Patients with HS who present to the emergency department vs ambulatory care for pain are significantly more likely to be ...